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The study on the cytotoxic properties of nordamnacanthal and damnacanthal, 
the anthraquinones isolated from the roots of Morinda elliptica (family Rubiaceae) 
were carried out on several cancerous cell lines including CEM-SS (T -lymphoblastic 
leukaemia), KU812F (chronic myelogeneous leukaemia), WEHI-3 (leukaemia), HT29 
(colon cancer) and HeLa (cervical adenocarcinoma). The degree of cytotoxicity of 
the compounds were defined by their abilities at certain concentration to cause 50% 
reduction in cell number relative to the untreated sample, and termed as IC50 value. 
CEM-SS was observed to be the most sensitive cell line towards nordamnacanthal and 
damnacanthal with the ICso values of 1.7 J1g1ml and 10 J1g1ml, respectively, as 
detected by the colorimetric tetrazolium-based assay (MTT). The compounds also 
showed cytotoxicity to the non-cancerous cell lines such as HF19 (lung fibroblast), 
human peripheral blood mononuclear (PBMC), 3T3 (mouse embryo) and Vero 
(monkey kidney fibroblast) but at very high concentrations (>30 J1g1ml). The 
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microscopic analysis on the treated CEM-SS cells including light microscopy without 
staining or following staining with haematology polychrome, Giemsa and Wright's 
stains, fluorescence microscopy following staining with acridine orange and 
propidium iodide, and scanning and transmission electron microscopy showed that 
these compounds induced two types of cell death, apoptosis and necrosis. 
At the molecular level, these compounds caused intemucleosomal DNA 
cleavage producing multiple of 1 80-200 bp fragments that are visible as a "ladder" on 
the agarose gel . The DNA fragmentation has been found to be due the activation of 
the Mg2+/Ca2+-dependent endonuclease. The induction of apoptosis by 
nordamnacanthal was different from the one induced by damnacanthal in a way that it 
occurs independently of ongoing transcription process. Nevertheless, in both cases, 
the process of dephosphorylation of protein phosphates 1 and 2A, the ongoing protein 
synthesis and the elevations of the cytosolic Ca2+ concentration were not needed for 
apoptosis to take place. Nordamnacanthal and damnacanthal at their ICso values 
showed different mechanism by which they exert their cytotoxic effects. 
Nordamnacanthal was found to have cytotoxic effect by inducing apoptosis in CEM­
SS cells. Damnacanthal, on the other hand, showed cytostatic effect by causing arrest 
at the GO/G 1 phase of the cell cycle. Nordamnacanthal was also found to reduce the 
expression of bcl-2, thus stimulating the process of apoptosis in CEM-SS cells. 
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Kajian ke atas ciri-ciri sitotoksik nordamnacanthal dan damnacanthal, 
antrakuinon daripada akar Morinda elliptica (keluarga Rubiaceae) telah dijalankan 
terhadap beberapa jujukan sel kanser seperti CEM-SS (T-limfoblastik leukemia), 
KU812F (kronik myelogeneous leukemia), WEHI-3 (leukemia), HT29 (kanser kolon) 
dan HeLa (adenokarsinoma serviks). Darjah kesitotoksikan sebatian-sebatian tersebut 
dinyatakan sebagai kebolehan mereka pada kepekatan tertentu yang menyebabkan 
pengurangan bilangan sel sebanyak 50% berbanding sam pel yang tidak dirawat 
(kawalan), yang diistilahkan sebagai nilai ICso. CEM-SS merupakan jujukan sel yang 
paling sensitif terhadap nordamnacanthal dan damnacanthal dengan nilai ICso 
masing-masing, 1.7 Jlglml dan 10 Jlglml, seperti yang dikesan menggunakan kaedah 
kolorimetri berasaskan tetrazolium (MTT). Sebatian-sebatian tersebut juga 
menunjukkan kesan sitotoksik terhadap jujukan sel bukan kanser yang digunakan di 
dalam kajian ini seperti HF19 (fibroblas pam-paru), human peripheral blood 
mononuclear (PBMC), 3T3 (embrio tikus) dan Vero (fibroblas ginjal monyet), tetapi 
v 
pada kepekatan yang amat tinggi (>30 �g/ml). Analisa mikroskopi terhadap sel-sel 
CEM-SS yang dirawat dengan sebatian-sebatian tersebut menggunakan mikroskop 
cahaya, tanpa atau selepas pewamaan dengan pewama hemotologi polikrom iaitu 
Giemsa dan Stain's, mikroskopi floresen selepas pewarnaan dengan akridin oren dan 
propidium iodida, dan mikroskopi elektron imbasan dan transmisi menunjukkan 
mereka menyebabkan dua jenis kematian iaitu apoptosis dan nekrosis. 
Pada peringkat molekul, sebatian-sebatian tersebut menyebabkan belahan di 
antara nukleosom pada DNA yang menghasilkan pecahan-pecahan bersaiz 180-200 
bp yang kelihatan seperti "tangga" pada gel agaros. Belahan DNA tersebut didapati 
disebabkan oleh pengaktifan aktiviti endonuklease bergantung-MgH/Ca2+. Induksi 
apoptosis oleh nordamnacanthal berbeza dari yang disebabkan oleh damnacanthal di 
mana ia berlaku tanpa bergantung kepada proses transkripsi yang berterusan. Walau 
bagaimanapun, di dalam kedua-dua kes, proses defosforilasi protein 1 dan 2A, sintesis 
protein yang berterusan serta peningkatan pada kepekatan Ca2+ sitos01 bdak 
diperlukan untuk apoptosis berlaku. Pada nilai ICso, nordamnacanthal dan 
damnacanthal didapati mempunyai mekanisma yang berbeza dalam menunjukkan 
kesan sitotoksik masing-masing. Nordamnacantha1 didapati mempunyai kesan 
sitotoksik dengan merangsang apoptosis dalam sel-sel CEM-SS. Sebaliknya, 
damnacanthal menunjukkan kesan sitostatik melalui penahanan pada fasa GO/G 1 
dalam kitaran sel. Nordamnacantal juga didapati mengurangkan penzahiran gen bc/-
2, lalu merangsang proses apoptosis di dalam sel-sel CEM-SS. 
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CHAPTER 1 
INTRODUCTION 
The incidence of cancer is increasing dramatically in the last decade world­
wide. The numbers representing the patients suffering from this cruel disorder 
continuously increased each year. In the United States, for instance, cancer is the 
second leading cause of death with estimated new cancer cases and deaths of 
1,284,900 and 555,500, respectively, for 2002 (Cancer Facts & Figures-2002, 2002). 
In Malaysia, even though there are no thorough and detailed statistical studies being 
done yet on the incidence of cancer, 35,000 new cases have been reported registered 
yearly, making it the fourth major cause of death in the country (National Cancer 
Registry of Malaysia, 2002). 
Cancer results from the uncontrolled growth and spread of abnormal cells. In 
addition to inherited genetic mutations and other biological factors, environmental 
influences such as chemicals and radiation (including sunlight) can increase the risk 
of having cancer. These factors may act individually or together. The disorder takes 
two forms of abnormal growth of tissue. One is benign and grows slowly. Its main 
distinction is that, once formed, it stays where it is. In all cancers, malignant tumours 
sometimes grow rapidly, and they spread, affecting not only healthy tissues nearby 
but also often invading vital parts of the body, such as the lungs, breasts and stomach. 
Cancer cells break away from the original growth and travel in the blood stream. 
They may also, at the same time, invade the lymphatic system that defends human 
body against bacterial invasion (Evans, 1991). 
As cancer is considered a systemic disease due to its metastatic properties, 
therefore, the cure from cancer will likely come from some type of systemic 
treatment. Chemotherapy could be such as systemic therapy for cancer (Verweij and 
de Jonge, 2000). Excellent results of chemotherapy have been obtained in a small 
range of cancers such as lymphoma and leukaemia (Garrett and Workman, 1999). 
Therefore, there is still a long way to go to achieve the necessary jump in the long­
term survival and curability of the major solid cancers especially those with metastatic 
forms. 
Comparatively, chemotherapy, the use of drugs to treat cancer, is a relatively 
young strategy to those two treatment modalities (surgery and radiotherapy). The 
steadily increasing interest in the development of drugs against cancer particularly 
started since the late 1950s (Verweij and de Jonge, 2000). In general, anticancer 
drugs destroy cancer cells by stopping them from growing or multiplying at one or 
more points in their life cycle. They interfere with cell replication to cause either 
tumour cell killing (cytotoxic drugs) or cessation of growth (cytostatic drugs) (Wilkes, 
1996). Even though chemotherapy can now be considered the main curative 
treatment, drugs for cancer are not only becoming impersonal but also expensive and 
highly toxic. They may be genotoxic, teratogenic and fetotoxic. In certain cases, the 
2 
drugs may increase the risk of developing a second cancer (secondary primary) 
(BIOMED*4090, 2002). 
As a consequence, based on the fact that human survival has always depended 
on plants whereby the early man relied entirely on them for food and medicine, 
scientist are making a move into searching for more effective and less harmful drugs 
to treat cancer from nature. Indeed, there are thousands of interesting and important 
medicines from nature. 
Natural products especially higher plants have historically served and remain 
as templates for the development of many important classes of drugs such as mitotic 
inhibitor and antibiotic. The World Health Organization (WHO) has estimated that at 
least 80 per cent of the world's population relies mainly, if not totally, on natural 
medicines. Even in industrialized countries, up to 40 per cent of all pharmaceuticals 
are derived from natural sources (Polunin and Robbins, 1992). The therapeutic 
properties of plants were subjected to continuous assessment and evaluation not only 
recently but over thousands of generations. Through previous efforts, plants have 
become a viable source of clinically useful anticancer agents such as 
vincaleukoblastine (vinblastine; Velban®) and leurocristine (vincristine; Oncovin®) 
from Catharanthus rose us (Neuss and Neuss, 1990), and taxol (paclitaxel; Taxol®) 
from Taxus brevifolia (Wani et al., 1971). 
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Currently, Malaysian tropical rain forests that contain a disproportionate share 
of the earth's plants with interesting pharmacologically active constituents provide a 
possible 'new avenue' with the emergence of a potent anti tumour compound, a 
styrylpyrone derivative (SPD) that has been extracted from a plant from a family of 
Annonaceae (Azimahtol Hawariah, 1999). It has been predicted to be another 
potential therapy for breast cancer besides the commercially available hormonal drug, 
tamoxifen. 
Cancer occurs when cells become abnormal and keep dividing and forming 
cells without control or order. The health of all multicellular organisms, including 
humans, depends not only on the ability to produce new cells but also on the ability of 
individual cells to self-destruct when they become superfluous or disordered, through 
a process called apoptosis or programmed cell death. The fact that some cells are 
behaving aberrantly, which eventually lead to the development of various disorders, 
particularly cancer, are due to the failure of the cells to undergo apoptosis (Reed and 
Tomaselli, 2000). 
Apoptosis (in classical Greek means "dropping off') is indeed an ongoing 
process and it is as fundamental to cellular and tissue physiology as are cell division 
and differentiation due to its pivotal role in normal organ development, deletion of 
vestigia] structures in embryogenesis, control of cell numbers and elimination of 
nonfunctional, harmful, abnormal or misplaced cells, as well as in many genetic and 
acquired diseases (Granville et ol., 1998). Cells experiencing apoptosis give 
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